Luger, Sebastian http://orcid.org/0000-0001-9236-2196
,
Jæger, Henriette S.
Dixon, Joanna
Bohmann, Ferdinand O.
Schaefer, JanHendrik
Richieri, Steven P.
Larsen, Karianne
Hov, Maren R.
Bache, Kristi G.
Foerch, Christian
Article History
First Online: 24 February 2020
Compliance with Ethical Standards
:
: FOB reports personal fees from Medtronic, non-financial support from Boehringer Ingelheim, grants from Stryker, outside the submitted work. JHS reports non-financial support from Boehringer Ingelheim and from Biogen (travel expenses), outside the submitted work. SPR is an employee of Banyan Biomarkers, and Banyan Biomarkers has submitted patents relative to the use of GFAP and UCH-L1. CF reports non-financial support from Banyan Biomarkers during the conduct of the study (Banyan Biomarkers provided the GFAP and UCH-L1 measurements free of charge), personal fees from Boehringer Ingelheim (advisory board honoraria), personal fees from Bristol Myers Squibb (speaker honoraria), personal fees from Boehringer Ingelheim (lecturer—stroke school), outside the submitted work. CF has a patent GFAP for the identification of intracerebral hemorrhage (EP1519194A1). All other authors report no conflicts of interest.
: The study protocol was approved by the institutional review board of both the Goethe-University Frankfurt am Main and the regional committees for medical and health research ethics in Norway. The study has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from patients and legal representatives, respectively.